ヨーロッパの医療用大麻市場 – 業界動向と2031年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの医療用大麻市場 – 業界動向と2031年までの予測

  • Pharmaceutical
  • Published Report
  • Jan 2024
  • Europe
  • 350 ページ
  • テーブル数: 460
  • 図の数: 24

ヨーロッパの医療用大麻市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2024 –2031
Diagram 市場規模(基準年)
USD 2,625.67 million
Diagram Market Size (Forecast Year)
USD 24,646.06 million
Diagram CAGR
%
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>ヨーロッパの医療用大麻市場、製品別(オイル、乾燥医療用大麻、医療用大麻カプセル、全花、粉末花、ベイプペン、クリームと保湿剤、その他)、原料(合成および天然)、種(大麻インディカ、サティバ、ハイブリッド)、誘導体(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)/デルタ-8-テトラヒドロカンナビノール、その他)、用途(疼痛管理、不安、筋肉のけいれん、吐き気、食欲不振、癌、関節炎、アルツハイマー病/偏頭痛、てんかん、うつ病および睡眠障害、多発性硬化症、自閉症、精神疾患、気分高揚、その他)、投与経路(経口液剤およびカプセル、喫煙、気化器、局所用薬、その他)、エンドユーザー(製薬業界、研究開発)センター、在宅ケア環境、病院、リハビリセンター、その他)、流通チャネル(B2B および B2C) - 2031 年までの業界動向と予測。

ヨーロッパの医療大麻市場

ヨーロッパの医療用大麻市場の分析と洞察

合法大麻は、ヨーロッパ諸国で最も急速に成長している産業の 1 つであり、食品、飲料、繊維、化学、その他多くの産業に大きな影響を与えています。麻の種子は、何千年もの間、栄養食品として使用されてきました。これらの種子には、THC (δ-9-テトラヒドロカンナビノール) がほとんど含まれていないため、医療用マリファナとは異なります。

ヨーロッパの医療用大麻市場

ヨーロッパの医療用大麻市場

データブリッジ・マーケット・リサーチは、医療用大麻市場は2024年から2031年の予測期間に33.6%のCAGRで成長し、2023年の26億2,567万米ドルから2031年には246億4,606万米ドルに達すると分析しています。 

レポートメトリック

詳細

予測期間

2024年から2031年

基準年

2023

歴史的な年

2022 (2016~2021年にカスタマイズ可能)

定量単位

収益(百万米ドル)

対象セグメント

製品(オイル、乾燥医療用大麻、医療用大麻カプセル、全花、粉末花、ベイプペン、クリームと保湿剤、その他)、原料(合成および天然)、種(大麻インディカ、サティバ、ハイブリッド)、誘導体(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)/デルタ-8-テトラヒドロカンナビノール、その他)、用途(疼痛管理、不安、筋肉のけいれん、吐き気、食欲不振、癌、関節炎アルツハイマー病/偏頭痛、てんかん、うつ病および睡眠障害、多発性硬化症、自閉症、精神疾患、気分高揚、その他)、投与経路(経口液剤およびカプセル、喫煙、ベイポライザー、外用剤、その他)、エンドユーザー(製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンター、その他)、流通チャネル(B2BおよびB2C)

対象国

ドイツ、フランス、イギリス、スペイン、イタリア、トルコ、オランダ、ベルギー、スイス、ギリシャ、ルクセンブルク、その他のヨーロッパ諸国

対象となる市場プレーヤー

Tilray、Althea Company Pty Ltd(Althea Group Holdings Limitedの子会社)、PharmaHemp、Aurora Cannabis Inc.、CANO​​PY GROWTH CORPORATION、Jazz Pharmaceuticals、Inc.、EcoGen Biosciences、GRASS & CO.、CANNARAY、Sanity Group GmbHなど

ヨーロッパの医療用大麻市場の定義

大麻はアサ科の植物から抽出される向精神薬です。長年にわたり医療に使用されてきました。慢性疼痛、癌、うつ病、糖尿病、関節炎、緑内障、てんかん、偏頭痛、エイズ、アルツハイマー病など、さまざまな病気の治療に幅広く応用されています。

ヨーロッパの医療用大麻市場の動向

ドライバー

  • 高齢者人口の増加

世界中で増加している高齢者人口は慢性疾患にかかりやすく、医師の診察を受ける回数が増えています。着実に高齢化が進む人口は、糖尿病、うつ病、認知症など、さまざまな健康状態に悩まされています。医療用大麻にはこれらの疾患を治療する特性があるため、増加している人口は重要な役割を果たしています。

  • 大麻の使用を必要とする病気の発生率の上昇

慢性疾患は世界中でよく見られる健康状態です。世界的に、成人の 3 人に 1 人が慢性疾患に苦しんでいます。神経疾患は、多くの国民の健康と生活の質に影響を及ぼしています。アルツハイマー病、がん、炎症性腸疾患、てんかんなどの慢性神経疾患は、入院、長期障害、生活の質の低下、そして死につながる可能性があります。

大麻は、カンナビス サティバという植物の精神活性剤を指す一般的な用語です。大麻は医療目的または娯楽目的で使用されてきました。カンナビノイドは神経系の受容体と反応するため、研究者はカンナビノイドが他の神経疾患の治療に役立つ可能性があると考えています。医療用大麻は、高齢者の慢性疾患による痛み、睡眠障害、不安などの症状を改善するのに安全かつ効果的です。

ヨーロッパの医療用大麻市場

機会

  • 市場参加者による戦略的取り組み

ヨーロッパでは、慢性膝疾患の罹患率と発症率の上昇、膝関節炎と半月板損傷の先進的治療法、満たされていない医療ニーズにより、膝疾患を治療するための医薬品の需要が高まっています。慢性膝疾患の発症率や症例の増加、先進的治療法の利用可能性などの要因により、整形外科リハビリテーション療法の必要性が高まっており、市場の需要を満たすために、小規模および大規模な市場プレーヤーがさまざまな戦略を活用しています。

  • 研究開発(R&D)活動の増加による新製品開発

大麻の合法化に伴う需要の急増により、より優れた製品株と配送システムの開発の必要性が高まっています。そのため、多くの企業が大麻の遺伝子改良戦略を検証するための研究開発活動を行っています。

企業は、収穫量の多い品種、除草剤耐性の向上、THC含有量の低さ、大麻作物の収穫と市場品質の向上に非常に力を入れています。品種が改良されるにつれて、より高品質の大麻が生産され、高品質の種子に対する需要が高まります。したがって、新しい製品の開発は市場にとってチャンスとなることが期待されます。

制約/課題

• 大麻の使用と過剰摂取に関連する長期的および短期的な副作用

整形外科専門医は、インプラントの使用と薬剤の服用中に特定のリスクを観察します。膝関節置換手術では、手術または欠陥のあるインプラントに起因する合併症が起こります。膝関節手術後の最も深刻な合併症の 1 つはインプラントの緩みであり、最も一般的なのは痛みです。緩みは骨折、不安定性、および深刻な転倒を引き起こす可能性があります。ほぼすべての深刻な合併症には再手術が必要です。直面するリスクは、機械的リスク、膝関節インプラントの緩み、および身体的痛みです。

マリファナはアルコールに次いで2番目に多く使用されている向精神薬です。大麻植物から抽出されるTHCを多く含む樹脂の喫煙が増加しており、消費者に深刻な緊急事態を引き起こしています。

  • 熟練した人材の不足

大麻業界は、供給不足、製品制限、厳格な規制に直面しているだけでなく、業界を円滑に運営するために必要な熟練した人材にも直面しています。大麻業界は、新たな候補者の懸念と熟練した人材の不足に対処しています。以前は禁止されていた物質を扱うという汚名から専門知識やセキュリティまで、業界はこれらすべての課題に直面しています。

最近の開発

  • 2020年5月、ティルレイは欧州連合基準のGMP認証を取得したと発表しました。これにより、医療用大麻抽出物を自社で製造し、完成した医療用大麻製品を輸出することが可能になりました。これにより、同社は事業を拡大することができました。
  • 2022年2月、サニティメディカルの事業部門であるサニティグループGmbHは、ドイツにおける大麻療法の遠隔医療を強化するために遠隔医療プラットフォームのTelaleafと契約を締結した。

ヨーロッパの医療用大麻市場の範囲

ヨーロッパの医療用大麻市場は、製品、供給源、種、派生品、用途、投与経路、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメントの成長は、業界のわずかな成長セグメントを分析するのに役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

製品

  •  乾燥医療用大麻
  •  医療用大麻カプセル
  •  ベイプペン
  •  花全体
  •  クリーム&保湿剤
  •  グラウンドフラワー
  •  その他

製品に基づいて、市場はオイル、医療用大麻カプセル、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤などに分類されます。

ソース

  • 自然
  • 合成

供給源に基づいて、市場は合成と天然に分類されます。

  • サティバ
  • ハイブリッド
  • 大麻インディカ

種に基づいて、市場はサティバ、ハイブリッド、およびインディカ大麻に分類されます。

デリバティブ

  • カンナビジオール(CBD)
  • テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール
  • その他

誘導体に基づいて、市場はカンナビジオール (CBD)、テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール、その他に分類されます。

応用

  • 疼痛管理
  • 不安
  •  筋肉のけいれん
  •  吐き気
  •  食欲不振
  •  癌
  •  関節炎
  •  アルツハイマー病/片頭痛
  •  てんかん
  •  うつ病と睡眠障害
  •  多発性硬化症
  •  自閉症
  •  精神衛生状態
  •  エレベート モッド
  •  その他

用途に基づいて、市場は、疼痛管理、不安、筋肉のけいれん、吐き気、食欲不振、癌、関節炎、アルツハイマー病/片頭痛、てんかん、うつ病および睡眠障害、多発性硬化症、自閉症、精神疾患、エレベート モッド、その他に分類されます。

投与経路

  • 経口液剤およびカプセル剤
  • 喫煙
  • 局所用薬
  • 気化器
  • その他

投与経路に基づいて、市場は経口液剤とカプセル剤、喫煙、局所用、気化器、その他に分類されます。

エンドユーザー

  • 在宅ケア環境
  • 病院
  • リハビリセンター
  • 製薬業界
  • 研究開発センター
  • その他

エンドユーザーに基づいて、市場は在宅ケア環境、病院、リハビリセンター、製薬業界、研究開発センター、その他に分類されます。

流通チャネル

  • B2C
  • 企業向け

流通チャネルに基づいて、市場は B2C と B2B に分類されます。

ヨーロッパの医療用大麻市場

ヨーロッパの医療用大麻市場: 地域分析/洞察

ヨーロッパの医療用大麻市場は、製品、供給源、種、派生物、用途、投与経路、最終ユーザー、流通チャネルに基づいて分類されています。

ヨーロッパの医療用大麻市場レポートで取り上げられている国は、ドイツ、フランス、イギリス、スペイン、イタリア、トルコ、オランダ、ベルギー、スイス、ギリシャ、ルクセンブルク、およびその他のヨーロッパ諸国です。

ドイツでは、膝関節症、膝関節形成術、さまざまな整形外科センターの増加により、ドイツが市場を支配すると予想されています。

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、地域ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

競争環境とシェア分析: ヨーロッパの医療用大麻市場

ヨーロッパの医療大麻市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、生産能力、会社の長所と短所、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、ヨーロッパの医療大麻市場に関連する会社の焦点にのみ関連しています。

ヨーロッパの医療用大麻市場で活動している主要企業としては、Tilray、Althea Company Pty Ltd(Althea Group Holdings Limitedの子会社)、PharmaHemp、Aurora Cannabis Inc.、CANO​​PY GROWTH CORPORATION、Jazz Pharmaceuticals, Inc.、EcoGen Biosciences、GRASS & CO.、CANNARAY、Sanity Group GmbHなどが挙げられます。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe MEDICAL CANNABIS market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. EUROPE MEDICAL CANNABIS MARKET: REGULATIONS
    1. UNITED STATES
    2. CANADA
    3. AUSTRALIA
    4. THAILAND
  6. EUROPE MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS
    1. CULTIVATORS AND GROWERS
    2. MANUFACTURER AND PRODUCER
    3. TESTERS
    4. WHOLESALE AND DISTRIBUTORS
    5. RETAILERS
  7. Market Overview
    1. DRIVERS
      1. INCREASED MEDICINAL USE
      2. LEGALIZATION OF CANNABIS
      3. INITIATIVES TAKEN BY MANUFACTURERS
      4. INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
      5. FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
    2. RESTRAINTS
      1. COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
      2. LONG TERM USE CAN CAUSE ADVERSE EFFECTS
      3. HIGH COST
    3. OPPORTUNITIES
      1. NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
      2. INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
      3. GROWING GERIATRIC POPULATION
      4. INCREASING PREVALENCE OF CHRONIC DISEASES
    4. CHALLENGES
      1. RISE OF MARIJUANA BLACK MARKET
      2. SIDE EFFECTS RELATED TO THE USE OF CANNABIS
      3. SHORTAGE OF PERSONNEL
  8. IMPACT OF COVID-19 ON EUROPE MEDICAL CANNABIS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
    5. CONCLUSION:
  9. EUROPE MEDICAL CANNABIS MARKET, BY product
    1. overview
    2. oil
      1. By Type
        1. CBD Oil Concentrates
        2. CBD Vape Oil
        3. CBD Tinctures
      2. By Source
        1. Marijuana Based
        2. Hemp Based
      3. By Species
        1. Sativa
        2. Hybrid
        3. Cannabis Indica
    3. Dried Medical cannabis
      1. Cannabis Indica
      2. Sativa
      3. Hybrid
    4. medical cannabis capsules
      1. By Type
        1. Oil Based Cannabis Capsules
        2. Power Based Cannabis Capsules
        3. Others
      2. By Concentrates
        1. High CBD Capsules Digital
        2. High THC Capsule
        3. THC/CBD balanced capsule
        4. CBD Isolate Capsule
        5. By Species
        6. Sativa
        7. Hybrid
        8. Cannabis Indica
    5. vape pen
      1. Cannabis Indica
      2. Sativa
      3. Hybrid
    6. whole flower
      1. Sativa
      2. Hybrid
      3. Cannabis Indica
    7. CREAMS & MOISTURIZER
    8. Ground Flower
      1. Sativa
      2. Cannabis Indica
      3. Hybrid
    9. patch
    10. mask & serum
    11. cleanser
    12. others
  10. EUROPE MEDICAL CANNABIS MARKET, BY application
    1. overview
    2. pain management
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Creams & Moisturizer
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    3. anxiety
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Ground Flower
      5. Vape Pen
      6. Whole Flower
      7. Others
    4. muscle spasms
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Creams & Moisturizer
      6. Ground Flower
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    5. nausea
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Ground Flower
      5. Creams & Moisturizer
      6. Patch
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    6. appetite loss
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Ground Flower
      5. Whole Flower
      6. Vape Pen
      7. Patch
      8. Others
    7. cancer
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    8. arthritis
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Creams & Moisturizer
      7. Masks & Serum
      8. Whole Flower
      9. Vape Pen
      10. Cleanser
      11. Others
    9. alzheimer’s disease/Migranes
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    10. epilepsy
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    11. depression and sleep disorders
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Creams & Moisturizer
      6. Others
    12. multiple sclerosis
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    13. autism
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    14. mental health conditions
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    15. elevate Mood
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Creams & Moisturizer
      6. Masks & Serum
      7. Cleanser
      8. Others
    16. others
  11. EUROPE MEDICAL CANNABIS MARKET, BY derivatives
    1. overview
    2. CANNABIDIOL (CBD)
      1. Oil
      2. Medical Cannabis Capsules
      3. Ground Flower
      4. Patch
      5. Creams & Moisturizer
      6. Vape Pen
      7. Whole Flower
      8. Masks & Serum
      9. Cleanser
      10. Others
    3. tetrahydrocannabinol (thc)/Delta-8-TETRAHYDROCANNABINOL
      1. Oil
      2. Medical Cannabis Capsules
      3. Dried Medical Cannabis
      4. Ground Flower
    4. Patch
      1. Creams & Moisturizer
      2. Whole Flower
      3. Vape Pen
      4. Masks & Serum
      5. Cleanser
      6. Others
    5. CANNABIGEROL (CBG)
      1. Oil
      2. Whole Flower
      3. Medical cannabis and capsules
      4. Cleanser
    6. cannabinol (CBN)
    7. others
  12. EUROPE MEDICAL CANNABIS MARKET, BY source
    1. overview
    2. natural
    3. synthetic
  13. EUROPE MEDICAL CANNABIS MARKET, BY species
    1. overview
    2. sativa
    3. hybrid
    4. cannabis indica
  14. EUROPE MEDICAL CANNABIS MARKET, BY route of administration
    1. overview
    2. oral solutions and capsules
    3. smoking
    4. topicals
    5. vaporizers
    6. others
  15. EUROPE MEDICAL CANNABIS MARKET, BY end user
    1. overview
    2. homecare setting
    3. hospital
    4. rehab centers
    5. PHARMACEUTICAL INDUSTRY
    6. research and development centers
    7. others
  16. EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. B2C
      1. Pharmacies
      2. Conventional Stores
      3. Online Stores
      4. Others
    3. B2B
  17. Europe medical cannabis MARKET by geography
    1. europe
      1. germany
      2. italy
      3. u.k.
      4. NETHERLANDS
      5. switzerland
      6. france
      7. russia
      8. spain
      9. belgium
      10. rest of europe
  18. Europe Medical Cannabis market: COMPANY landscape
    1. company share analysis: Europe
  19. Swot analysis
  20. company profile
    1. MEDIPHARM LABS INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. APHRIA INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. tilray
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Zenabis Europe Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. AURORA CANNABIS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. gw pharmaceuticals plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Althea Company Pty Ltd (A subsidiary of Althea Group)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Apothecanna
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. bARNEY’S FARM
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Bioactive solutions, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. bol pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. CANNABIS SEEDS USA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. canopy growth corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Cresco Labs
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Crop King Seeds
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. discover health llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. EcoGen Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Elixinol Europe limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. endoca
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. EXTRACTAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    21. FOLIUM BIOSCIENCES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. GREENWICH BIOSCIENCES, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    23. HARMONY
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. HUMBOLDT SEED COMPANY
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    25. IDT AUSTRALIA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    26. kiehl’s (a subsidiary of L'Oréal)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    27. mary’s nutritionals, LLC
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    28. medical marijuana, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    29. MEDIFARM
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    30. pacific roots
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    31. pharmahemp
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    32. pure ratios
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    33. PEACE NATURALS PROJECT INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    34. seed Cellar
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    35. SEEDS FOR ME
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    36. THC EUROPE GROUP LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    37. upstate elevator supply co.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    38. vermont hemp health
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  21. questionnaire
  22. related reports

表のリスト

TABLE 1 Annual Cost of Cultivation:

TABLE 2 Annual Cost of Manufacturing:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 26 Europe MEDICAL CANNABIS market, By application, 2019-2028 (USD million)

TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 28 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by anxiety, By Region, 2021-2028 (USD Million)

TABLE 30 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 31 EUROPE muscle spasms IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 32 Europe muscle spasms in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 33 EUROPE nausea IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 34 Europe nausea in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 35 EUROPE appetite loss IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 36 Europe appetite loss in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 37 EUROPE cancer IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 38 Europe cancer in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 39 EUROPE arthritis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 40 Europe arthritis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 42 Europe ALZHEIMER’S DISEASE/MIGRANES in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 43 EUROPE epilepsy IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 44 Europe epilepsy in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 45 EUROPE depression and sleep disorders IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 46 Europe depression and sleep disorders in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 47 EUROPE multiple sclerosis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 48 Europe multiple sclerosis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 49 EUROPE autism IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 50 Europe autism in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 51 EUROPE mental health conditions IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 52 Europe mental health conditions in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 53 EUROPE elevate mood IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 54 Europe elevate mood in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 55 EUROPE others IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 65 Europe medical cannabis Market, BY source, 2019-2028 (USD MILLION)

TABLE 66 Europe natural in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 67 Europe synthetic in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 68 Europe medical cannabis Market, By Species, 2019-2028 (USD Million)

TABLE 69 Europe sativa in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 70 Europe hybrid in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 71 Europe cannabis indica in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 72 Europe medical cannabis Market, By route of administration, 2019-2028 (USD Million)

TABLE 73 Europe oral solutions and capsules in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 74 Europe smoking in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 75 Europe topicals in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 76 Europe vaporizers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 77 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 78 Europe medical cannabis Market, BY end user, 2019-2028 (USD MILLION)

TABLE 79 Europe homecare setting in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 80 Europe hospital in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 81 Europe rehab centers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 82 Europe pharmaceutical industry in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 83 Europe research and development centers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 84 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 85 Europe medical cannabis Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 86 Europe b2c in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 87 Europe b2C in medical cannabis Market, By distribution channel, 2019-2028 (USD Million)

TABLE 88 Europe b2b in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 89 europe medical cannabis Market, By COUNTRY, 2021-2028 (USD million)

TABLE 90 EUROPE medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 91 EUROPE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 92 EUROPE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 93 EUROPE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 94 EUROPE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 95 EUROPE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 96 EUROPE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 97 EUROPE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 98 EUROPE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 99 EUROPE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 100 EUROPE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 101 EUROPE medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 102 EUROPE medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 103 EUROPE medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 104 EUROPE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 105 EUROPE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 106 EUROPE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 107 EUROPE medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 108 EUROPE pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 109 EUROPE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 110 EUROPE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 111 EUROPE nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 112 EUROPE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 113 EUROPE cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 114 EUROPE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 115 EUROPE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 116 EUROPE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 117 EUROPE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 118 EUROPE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 119 EUROPE autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 120 EUROPE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 121 EUROPE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 122 EUROPE medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 123 EUROPE medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 124 EUROPE medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 125 EUROPE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 126 GERMANY medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 127 GERMANY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 128 GERMANY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 129 GERMANY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 130 GERMANY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 131 GERMANY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 132 GERMANY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 133 GERMANY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 134 GERMANY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 135 GERMANY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 136 GERMANY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 137 GERMANY medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 138 GERMANY medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 139 GERMANY medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 140 GERMANY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 141 GERMANY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 142 GERMANY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 143 GERMANY medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 144 GERMANY pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 145 GERMANY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 146 GERMANY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 147 GERMANY nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 148 GERMANY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 149 GERMANY cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 150 GERMANY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 151 GERMANY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 152 GERMANY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 153 GERMANY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 154 GERMANY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 155 GERMANY autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 156 GERMANY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 157 GERMANY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 158 GERMANY medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 159 GERMANY medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 160 GERMANY medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 161 GERMANY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 162 ITALY medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 163 ITALY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 164 ITALY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 165 ITALY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 166 ITALY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 167 ITALY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 168 ITALY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 169 ITALY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 170 ITALY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 171 ITALY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 172 ITALY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 173 ITALY medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 174 ITALY medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 175 ITALY medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 176 ITALY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 177 ITALY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 178 ITALY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 179 ITALY medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 180 ITALY pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 181 ITALY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 182 ITALY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 183 ITALY nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 184 ITALY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 185 ITALY cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 186 ITALY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 187 ITALY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 188 ITALY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 189 ITALY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 190 ITALY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 191 ITALY autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 192 ITALY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 193 ITALY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 194 ITALY medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 195 ITALY medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 196 ITALY medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 197 ITALY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 198 U.K. medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 199 U.K. type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 200 U.K. source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 201 U.K. species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 202 U.K. dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 203 U.K. type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 204 U.K. concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 205 U.K. species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 206 U.K. vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 207 U.K. whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 208 U.K. ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 209 U.K. medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 210 U.K. medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 211 U.K. medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 212 U.K. cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 213 U.K. tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 214 U.K. cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 215 U.K. medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 216 U.K. pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 217 U.K. anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 218 U.K. muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 219 U.K. nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 220 U.K. appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 221 U.K. cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 222 U.K. arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 223 U.K. alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 224 U.K. epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 225 U.K. depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 226 U.K. multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 227 U.K. autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 228 U.K. mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 229 U.K. elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 230 U.K. medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 231 U.K. medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 232 U.K. medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 233 U.K. B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 234 NETHERLANDS medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 235 NETHERLANDS type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 236 NETHERLANDS source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 237 NETHERLANDS species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 238 NETHERLANDS dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 239 NETHERLANDS type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 240 NETHERLANDS concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 241 NETHERLANDS species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 242 NETHERLANDS vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 243 NETHERLANDS whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 244 NETHERLANDS ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 245 NETHERLANDS medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 246 NETHERLANDS medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 247 NETHERLANDS medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 248 NETHERLANDS cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 249 NETHERLANDS tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 250 NETHERLANDS cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 251 NETHERLANDS medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 252 NETHERLANDS pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 253 NETHERLANDS anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 254 NETHERLANDS muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 255 NETHERLANDS nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 256 NETHERLANDS appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 257 NETHERLANDS cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 258 NETHERLANDS arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 259 NETHERLANDS alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 260 NETHERLANDS epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 261 NETHERLANDS depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 262 NETHERLANDS multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 263 NETHERLANDS autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 264 NETHERLANDS mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 265 NETHERLANDS elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 266 NETHERLANDS medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 267 NETHERLANDS medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 268 NETHERLANDS medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 269 NETHERLANDS B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 270 SWITZERLAND medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 271 SWITZERLAND type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 272 SWITZERLAND source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 273 SWITZERLAND species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 274 SWITZERLAND dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 275 SWITZERLAND type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 276 SWITZERLAND concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 277 SWITZERLAND species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 278 SWITZERLAND vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 279 SWITZERLAND whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 280 SWITZERLAND ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 281 SWITZERLAND medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 282 SWITZERLAND medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 283 SWITZERLAND medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 284 SWITZERLAND cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 285 SWITZERLAND tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 286 SWITZERLAND cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 287 SWITZERLAND medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 288 SWITZERLAND pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 289 SWITZERLAND anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 290 SWITZERLAND muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 291 SWITZERLAND nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 292 SWITZERLAND appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 293 SWITZERLAND cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 294 SWITZERLAND arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 295 SWITZERLAND alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 296 SWITZERLAND epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 297 SWITZERLAND depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 298 SWITZERLAND multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 299 SWITZERLAND autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 300 SWITZERLAND mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 301 SWITZERLAND elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 302 SWITZERLAND medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 303 SWITZERLAND medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 304 SWITZERLAND medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 305 SWITZERLAND B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 306 FRANCE medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 307 FRANCE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 308 FRANCE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 309 FRANCE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 310 FRANCE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 311 FRANCE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 312 FRANCE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 313 FRANCE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 314 FRANCE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 315 FRANCE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 316 FRANCE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 317 FRANCE medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 318 FRANCE medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 319 FRANCE medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 320 FRANCE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 321 FRANCE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 322 FRANCE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 323 FRANCE medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 324 FRANCE pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 325 FRANCE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 326 FRANCE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 327 FRANCE nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 328 FRANCE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 329 FRANCE cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 330 FRANCE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 331 FRANCE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 332 FRANCE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 333 FRANCE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 334 FRANCE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 335 FRANCE autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 336 FRANCE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 337 FRANCE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 338 FRANCE medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 339 FRANCE medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 340 FRANCE medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 341 FRANCE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 342 RUSSIA medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 343 RUSSIA type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 344 RUSSIA source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 345 RUSSIA species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 346 RUSSIA dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 347 RUSSIA type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 348 RUSSIA concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 349 RUSSIA species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 350 RUSSIA vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 351 RUSSIA whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 352 RUSSIA ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 353 RUSSIA medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 354 RUSSIA medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 355 RUSSIA medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 356 RUSSIA cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 357 RUSSIA tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 358 RUSSIA cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 359 RUSSIA medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 360 RUSSIA pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 361 RUSSIA anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 362 RUSSIA muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 363 RUSSIA nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 364 RUSSIA appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 365 RUSSIA cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 366 RUSSIA arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 367 RUSSIA alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 368 RUSSIA epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 369 RUSSIA depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 370 RUSSIA multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 371 RUSSIA autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 372 RUSSIA mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 373 RUSSIA elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 374 RUSSIA medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 375 RUSSIA medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 376 RUSSIA medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 377 RUSSIA B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 378 SPAIN medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 379 SPAIN type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 380 SPAIN source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 381 SPAIN species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 382 SPAIN dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 383 SPAIN type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 384 SPAIN concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 385 SPAIN species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 386 SPAIN vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 387 SPAIN whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 388 SPAIN ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 389 SPAIN medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 390 SPAIN medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 391 SPAIN medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 392 SPAIN cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 393 SPAIN tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 394 SPAIN cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 395 SPAIN medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 396 SPAIN pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 397 SPAIN anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 398 SPAIN muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 399 SPAIN nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 400 SPAIN appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 401 SPAIN cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 402 SPAIN arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 403 SPAIN alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 404 SPAIN epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 405 SPAIN depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 406 SPAIN multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 407 SPAIN autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 408 SPAIN mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 409 SPAIN elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 410 SPAIN medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 411 SPAIN medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 412 SPAIN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 413 SPAIN B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 414 BELGIUM medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 415 BELGIUM type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 416 BELGIUM source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 417 BELGIUM species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 418 BELGIUM dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 419 BELGIUM type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 420 BELGIUM concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 421 BELGIUM species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 422 BELGIUM vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 423 BELGIUM whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 424 BELGIUM ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 425 BELGIUM medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 426 BELGIUM medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 427 BELGIUM medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 428 BELGIUM cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 429 BELGIUM tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 430 BELGIUM cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 431 BELGIUM medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 432 BELGIUM pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 433 BELGIUM anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 434 BELGIUM muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 435 BELGIUM nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 436 BELGIUM appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 437 BELGIUM cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 438 BELGIUM arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 439 BELGIUM alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 440 BELGIUM epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 441 BELGIUM depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 442 BELGIUM multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 443 BELGIUM autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 444 BELGIUM mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 445 BELGIUM elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 446 BELGIUM medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 447 BELGIUM medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 448 BELGIUM medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 449 BELGIUM B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 450 rest of europe medical cannabis Market, By product, 2021-2028 (USD million)

図表一覧

FIGURE 1 Europe medical cannabis market: segmentation

FIGURE 2 Europe medical cannabis market: data triangulation

FIGURE 3 Europe medical cannabis market: DROC ANALYSIS

FIGURE 4 Europe medical cannabis market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe medical cannabis market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe medical cannabis market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe medical cannabis market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE medical cannabis MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe medical cannabis market: vendor share analysis

FIGURE 10 Europe medical cannabis market: SEGMENTATION

FIGURE 11 increasing medicinal use and legalization of medical cannabis are expected to drive THE Europe medical cannabis market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 oil segment is expected to account for the largest share of the Europe medical cananbis market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MEDICAL CANNABIS MARKET

FIGURE 14 Europe MEDICAL CANNABIS market: BY product, 2020

FIGURE 15 Europe MEDICAL CANNABIS market: BY product, 2021-2028 (USD Million)

FIGURE 16 Europe MEDICAL CANNABIS market: BY product, CAGR (2021-2028)

FIGURE 17 Europe MEDICAL CANNABIS market: BY product, LIFELINE CURVE

FIGURE 18 Europe MEDICAL CANNABIS market: BY application, 2020

FIGURE 19 Europe MEDICAL CANNABIS market: BY application, 2021-2028 (USD Million)

FIGURE 20 Europe MEDICAL CANNABIS market: BY application, CAGR (2021-2028)

FIGURE 21 Europe MEDICAL CANNABIS market: BY application, LIFELINE CURVE

FIGURE 22 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2020

FIGURE 23 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2021-2028 (USD Million)

FIGURE 24 Europe MEDICAL CANNABIS market: BY DERIVATIVES, CAGR (2021-2028)

FIGURE 25 Europe MEDICAL CANNABIS market: BY DERIVATIVES, LIFELINE CURVE

FIGURE 26 Europe MEDICAL CANNABIS market: BY source, 2020

FIGURE 27 Europe MEDICAL CANNABIS market: BY source, 2021-2028 (USD Million)

FIGURE 28 Europe MEDICAL CANNABIS market: BY source, CAGR (2021-2028)

FIGURE 29 Europe MEDICAL CANNABIS market: BY source, LIFELINE CURVE

FIGURE 30 Europe MEDICAL CANNABIS market: BY species, 2020

FIGURE 31 Europe MEDICAL CANNABIS market: BY species, 2021-2028 (USD Million)

FIGURE 32 Europe MEDICAL CANNABIS market: BY species, CAGR (2021-2028)

FIGURE 33 Europe MEDICAL CANNABIS market: BY species, LIFELINE CURVE

FIGURE 34 Europe MEDICAL CANNABIS market: BY route of administration, 2020

FIGURE 35 Europe MEDICAL CANNABIS market: BY route of administration, 2021-2028 (USD Million)

FIGURE 36 Europe MEDICAL CANNABIS market: BY route of administration, CAGR (2021-2028)

FIGURE 37 Europe MEDICAL CANNABIS market: BY route of administration, LIFELINE CURVE

FIGURE 38 Europe MEDICAL CANNABIS market: BY end user, 2020

FIGURE 39 Europe MEDICAL CANNABIS market: BY end user, 2021-2028 (USD Million)

FIGURE 40 Europe MEDICAL CANNABIS market: BY end user, CAGR (2021-2028)

FIGURE 41 Europe MEDICAL CANNABIS market: BY end user, LIFELINE CURVE

FIGURE 42 Europe MEDICAL CANNABIS market: BY distribution channel, 2020

FIGURE 43 Europe MEDICAL CANNABIS market: BY distribution channel , 2021-2028 (USD Million)

FIGURE 44 Europe MEDICAL CANNABIS market: BY distribution channel , CAGR (2021-2028)

FIGURE 45 Europe MEDICAL CANNABIS market: BY distribution channel, LIFELINE CURVE

FIGURE 46 europe medical cannabis MARKET: SNAPSHOT (2020)

FIGURE 47 europe medical cannabis MARKET: BY COUNTRY (2020)

FIGURE 48 europe medical cannabis MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 europe medical cannabis MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 europe medical cannabis MARKET: BY type (2021-2028)

FIGURE 51 Europe Medical Cannabis market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Medical Cannabis Market size will be worth USD 24,646.06 million by 2031 during the forecast period.
The Medical Cannabis Market growth rate is 33.6% during the forecast period.
The Rise in the Geriatric Population and Rise in Incidence of Diseases that Require the Use of Cannabis are the growth drivers of the Europe Medical Cannabis Market.
The product, source, species, derivatives, application, route of administration, end user, and distribution channel are the factors on which the Europe Medical Cannabis Market research is based.
The major companies in the Europe Medical Cannabis Market are Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY, and Sanity Group GmbH.